Protagonist Therapeutics PTGX Interest Income
Interest Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's interest income?
- Protagonist Therapeutics (PTGX) reported interest income of $5.88M in Q1 2026.
- How has Protagonist Therapeutics's interest income changed year-over-year?
- Protagonist Therapeutics's interest income decreased by 22.4% year-over-year, from $7.57M to $5.88M.
- What is the long-term trend for Protagonist Therapeutics's interest income?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's interest income has grown at a 183.9% compound annual growth rate (CAGR), from $443K to $28.79M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.